Semble secures £30m Series C from Revaia to scale European private healthcare platform
The London-based health technology provider has raised £30m led by Revaia to expand its infrastructure across Europe.
Share allotment filed at Companies House
Semble provides a connected practice management platform that consolidates clinical records, billing, and scheduling for private healthcare providers.
London-based health technology provider Semble has secured £30m in a Series C funding round led by Paris growth investor Revaia. The round also drew participation from new backer Partech alongside returning investors Mercia Ventures and Octopus Ventures, bringing the company total capitalisation to approximately £57m.
The business will deploy the new capital to scale its connected practice management infrastructure across Europe, building on its recent market entry in France. Semble currently provides administrative and clinical software for 1,700 healthcare businesses and 16,000 professionals in the UK.
The fundraising follows a period of rapid growth driven by rising demand for private outpatient care as patients seek alternatives to extended public waiting lists. The platform integrates scheduling, billing, clinical records, and prescriptions alongside 1,200 external third-party tools.
From the founder
"For years, the industry has tried to address complex systemic issues through disconnected point solutions, but fragmented technology often adds operational complexity for healthcare providers and creates an interrupted experience for patients. What healthcare organisations need is intelligent orchestration across the entire care journey. The practices and groups that win over the next decade will be the ones that deliver the best patient experience end-to-end."
Christoph Lippuner
CEO and Co-founder at Semble
Investor perspective
"Semble is building the system of action for modern healthcare — a platform with genuine clinical depth, real scale and the trust of healthcare providers across the UK and France. The European healthcare market is being reshaped — by technology, by demand and by shifting patient expectations — and Semble is exceptionally well positioned to lead it."
Morgan Kessous
Partner, Revaia
Use of funds
- 01Expand into international markets
